Because of You, We Can Fight COVID-19
Vitalant is collecting plasma from people who have recovered from COVID-19. Called “convalescent plasma,” it contains antibodies to the SARS-CoV-2 coronavirus, which can be given to patients currently fighting COVID-19.* Together, we can save lives.
To be eligible, you must have had COVID-19 symptoms plus:
- A prior laboratory diagnosis of COVID-19, either by a positive nasal/oral swab test OR a positive test for SARS-CoV-2 antibodies requested by your health care provider
- Complete resolution of symptoms for at least 28 days
- Meet all other donor eligibility for an automated plasma donation
If you meet all the criteria above, book an appointment online by entering your zip code
. After submitting your zip code, use any donate button and schedule a COVID plasma appointment (or plasma appointment if COVID plasma is not an option).
SET MY ZIP CODE
Blood donors are NOT tested for coronavirus. Do not donate blood if you are sick.
NOTE: Donors who receive a positive antibody test result from Vitalant or any other blood bank or community screening effort are NOT automatically qualified to give a convalescent plasma donation. We strongly encourage you to come back and donate plasma so we can test your blood again per new FDA guidance to further determine your antibody status. If your blood tests positive again for antibodies, your plasma could go to a COVID-19 patient and you would be eligible to give future convalescent plasma donations.
If you have questions, call 866-CV-PLSMA (866-287-5762).
How Will Vitalant Use My Plasma?
The Food and Drug Administration is allowing the transfusion of convalescent plasma as an investigational treatment. Vitalant is working with hospitals to collect, process and distribute the plasma for treatment in patients with active, serious COVID-19 infections.
Additionally, Vitalant Research Institute is developing technologies to detect and quantify virus-fighting antibodies to COVID-19.
Learn more >
What Should I Expect When Donating Plasma?
Plasma is the liquid portion of the blood. A plasma donation only takes about an hour; however, with the medical screening and review of your health history, you should plan for about 2 hours total. We use a specialized process called apheresis that allows Vitalant to separate and collect only specific blood components—like plasma—while safely returning the remaining components to the donor.
Can I Donate Convalescent Plasma More Than Once?
Absolutely! If you’ve already had a diagnostic test to confirm you had COVID-19 and/or a positive antibody test ordered by your health care provider, you can schedule a convalescent plasma donation every 28 days (and up to every week, with Vitalant medical director approval!). To schedule your next donation you can:
1) ask one of our staff to book it before you leave the donation center;
2) book a regular plasma donation using our online scheduler, or
3) call 866-CV-PLSMA (866-287-5762).
There is an ongoing need for convalescent plasma to help COVID-19 patients and with each plasma donation you make, you can help more patients!
My result is positive for the Vitalant COVID-19 Supplemental antibody test. Can I donate convalescent plasma now?
Yes! If you meet all other eligibility requirements for a plasma donation, you can donate convalescent plasma to help COVID-19 patients. Please schedule online for a plasma appointment or call 866-CV-PLSMA to make your appointment.
Are You a Patient or Family Member?
If you or a loved one are currently battling COVID-19, we absolutely hear your urgent need. Convalescent plasma treatment is a promising light in these dark times. Vitalant does not provide convalescent plasma directly to individuals. Please contact your clinician to explore the potential for receiving this treatment.
*COVID-19 convalescent plasma has not been approved or licensed by the FDA; COVID-19 convalescent plasma has been authorized by the FDA under an emergency use authorization (EUA); COVID-19 convalescent plasma is authorized only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of drugs and biological products during the COVID-19 pandemic under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.